Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability of a rapid dose titration
regimen of subcutaneous Remodulin® therapy in patients with PAH.